14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

Trading levels for AKTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.22 2.24 %
R2 1.21 1.28 %
R1 1.20 0.683 %
Current price: 1.19
Support S1 1.18 -1.24 %
S2 1.17 -1.84 %
S3 1.16 -2.80 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.44 21.01 %
R2 1.30 9.24 %
R1 1.21 1.68 %
Current price 1.19
Support S1 1.18 -0.84%
S2 1.16 -2.90%
S3 1.10 -7.56%

AKTX Predictions History

2 years ago
JS predicted that AKTX for 2021-06-22 is going $1.66 (-95.12%)

2 years ago
dhruv.244786 predicted that AKTX for 2021-06-22 is going

Rank:

2 years ago
Ulwarthy predicted that AKTX for 2021-06-22 is going $1.77 (-94.79%)

Rank:

3 years ago
Omar.Elgusbi.87144 predicted that AKTX for 2020-06-05 is going

Rank:

3 years ago
Joseph.Harrison.118997 predicted that AKTX for 2020-06-05 is going $2.30 (-95.34%)

Rank:

3 years ago
Ramzi Amer predicted that AKTX for 2020-06-05 is going $2.30 (-95.34%)

Rank:

3 years ago
Alan Stevenson predicted that AKTX for 2020-06-05 is going $2.49 (-94.96%)

Rank:

4 years ago
NameNotImportant predicted that AKTX for 2019-04-29 is going $3.34 (-95.32%)

5 years ago
NameNotImportant predicted that AKTX for 2019-04-23 is going $3.54 (-95.44%)

5 years ago
Rookie predicted that AKTX for 2019-03-20 is going $5.30 (-93.54%)

Rank:
Click to get the best stock tips daily for free!

About Akari Therapeutics Plc

Akari Therapeutics Plc Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ... AKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT